These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11317658)

  • 1. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort.
    Kupila A; Muona P; Simell T; Arvilommi P; Savolainen H; Hämäläinen AM; Korhonen S; Kimpimäki T; Sjöroos M; Ilonen J; Knip M; Simell O;
    Diabetologia; 2001 Mar; 44(3):290-7. PubMed ID: 11317658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.
    Kukko M; Virtanen SM; Toivonen A; Simell S; Korhonen S; Ilonen J; Simel O; Knip M
    Diabetes Care; 2004 Mar; 27(3):676-81. PubMed ID: 14988284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M
    J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DQB1 genotypes and islet cell antibodies in the identification of siblings at risk for insulin-dependent diabetes (IDDM) in Finland. Childhood Diabetes in Finland (DiMe) Study Group.
    Reijonen H; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    J Autoimmun; 1994 Oct; 7(5):675-86. PubMed ID: 7840859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
    Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune and clinical characteristics of type I diabetes in children with different genetic risk loads defined by HLA-DQB1 alleles. Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Sabbah E; Vähäsalo P; Lounamaa R; Akerblom HK; Reijonen H; Ilonen J
    Clin Sci (Lond); 1998 Mar; 94(3):263-9. PubMed ID: 9616260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study.
    Lönnrot M; Korpela K; Knip M; Ilonen J; Simell O; Korhonen S; Savola K; Muona P; Simell T; Koskela P; Hyöty H
    Diabetes; 2000 Aug; 49(8):1314-8. PubMed ID: 10923631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study.
    Akerblom HK; Virtanen SM; Ilonen J; Savilahti E; Vaarala O; Reunanen A; Teramo K; Hämäläinen AM; Paronen J; Riikjärv MA; Ormisson A; Ludvigsson J; Dosch HM; Hakulinen T; Knip M;
    Diabetologia; 2005 May; 48(5):829-37. PubMed ID: 15838685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.
    Kimpimäki T; Kupila A; Hämäläinen AM; Kukko M; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4782-8. PubMed ID: 11600541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.
    Näntö-Salonen K; Kupila A; Simell S; Siljander H; Salonsaari T; Hekkala A; Korhonen S; Erkkola R; Sipilä JI; Haavisto L; Siltala M; Tuominen J; Hakalax J; Hyöty H; Ilonen J; Veijola R; Simell T; Knip M; Simell O
    Lancet; 2008 Nov; 372(9651):1746-55. PubMed ID: 18814906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive genetic screening for type-1 diabetes in the Hungarian population].
    Hermann R; Soltész G
    Orv Hetil; 2004 Feb; 145(7):337-42. PubMed ID: 15049049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical differences within Finland in the frequency of HLA-DQ genotypes associated with type 1 diabetes susceptibility. The Childhood Diabetes in Finland Study Group.
    Ilonen J; Reijonen H; Green A; Reunanen A; Knip M; Simell O; Akerblom HK
    Eur J Immunogenet; 2000 Aug; 27(4):225-30. PubMed ID: 10998087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.
    Redondo MJ; Babu S; Zeidler A; Orban T; Yu L; Greenbaum C; Palmer JP; Cuthbertson D; Eisenbarth GS; Krischer JP; Schatz D;
    J Clin Endocrinol Metab; 2006 May; 91(5):1705-13. PubMed ID: 16464953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study).
    Buzzetti R; Galgani A; Petrone A; Del Buono ML; Erlich HA; Bugawan TL; Lorini R; Meschi F; Multari G; Pozzilli P; Locatelli M; Bottazzo G; Di Mario U
    Diabetes Metab Res Rev; 2004; 20(2):137-43. PubMed ID: 15037989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years.
    Till AM; Kenk H; Rjasanowski I; Wassmuth R; Walschus U; Kerner W; Schlosser M
    Diabet Med; 2015 Aug; 32(8):1008-16. PubMed ID: 25523979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.